James S Andrews1, Laura Trupin2, Catherine L Hough3, David I Daikh4, Edward H Yelin2, Patricia P Katz2. 1. Department of Medicine, University of Washington, Seattle, USA. Electronic address: jsa1@uw.edu. 2. Department of Medicine, University of California San Francisco, San Francisco, USA. 3. Department of Medicine, University of Washington, Seattle, USA. 4. Department of Medicine, University of California San Francisco, San Francisco, USA; Department of Medicine, San Francisco VA Medical Center, San Francisco, USA.
Abstract
OBJECTIVES: Muscle strength is an important determinant of physical function in women with systemic lupus erythematosus (SLE). Serum biomarkers of inflammation, including interleukin-6 (IL-6) and C-Reactive Protein (CRP), are associated with differences in muscle strength among individuals without rheumatologic disease. We examined whether serum levels of IL-6 and CRP are associated with upper and lower extremity muscle strength among adult women with SLE. METHODS: One hundred thirty-six women with SLE participated in this cross-sectional study. High-sensitivity CRP was analyzed by nephelometry. IL-6 serum levels were analyzed by high sensitivity enzyme-linked immunosorbent assay. Upper and lower extremity muscle strength were assessed by grip strength and peak torque of knee extension and flexion, respectively. Regression analyses modeled associations of CRP and IL-6 with upper and lower extremity muscle strength controlling for age, SLE duration, physical activity, prednisone use, BMI, plaquenil use, and pain. RESULTS: Higher serum levels of IL-6 and CRP were associated with significantly weaker upper and lower extremity muscle strength even when controlling for covariates. CONCLUSIONS: Increased serum IL-6 and CRP are associated with clinically significant differences in upper and lower extremity muscle strength and may be useful in identifying those at risk for weakness and decreased physical function.
OBJECTIVES: Muscle strength is an important determinant of physical function in women with systemic lupus erythematosus (SLE). Serum biomarkers of inflammation, including interleukin-6 (IL-6) and C-Reactive Protein (CRP), are associated with differences in muscle strength among individuals without rheumatologic disease. We examined whether serum levels of IL-6 and CRP are associated with upper and lower extremity muscle strength among adult women with SLE. METHODS: One hundred thirty-six women with SLE participated in this cross-sectional study. High-sensitivity CRP was analyzed by nephelometry. IL-6 serum levels were analyzed by high sensitivity enzyme-linked immunosorbent assay. Upper and lower extremity muscle strength were assessed by grip strength and peak torque of knee extension and flexion, respectively. Regression analyses modeled associations of CRP and IL-6 with upper and lower extremity muscle strength controlling for age, SLE duration, physical activity, prednisone use, BMI, plaquenil use, and pain. RESULTS: Higher serum levels of IL-6 and CRP were associated with significantly weaker upper and lower extremity muscle strength even when controlling for covariates. CONCLUSIONS: Increased serum IL-6 and CRP are associated with clinically significant differences in upper and lower extremity muscle strength and may be useful in identifying those at risk for weakness and decreased physical function.
Authors: M L A S Santos; W F Gomes; D S Pereira; D M G Oliveira; J M D Dias; E Ferrioli; L S M Pereira Journal: Arch Gerontol Geriatr Date: 2011 May-Jun Impact factor: 3.250
Authors: James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz Journal: Arthritis Care Res (Hoboken) Date: 2015-08 Impact factor: 4.794
Authors: S Yende; G W Waterer; E A Tolley; A B Newman; D C Bauer; D R Taaffe; R Jensen; R Crapo; S Rubin; M Nevitt; E M Simonsick; S Satterfield; T Harris; S B Kritchevsky Journal: Thorax Date: 2005-11-11 Impact factor: 9.139
Authors: James S Andrews; Laura Trupin; Gabriela Schmajuk; Jennifer Barton; Mary Margaretten; Jinoos Yazdany; Edward H Yelin; Patricia P Katz Journal: Arthritis Care Res (Hoboken) Date: 2015-01 Impact factor: 4.794
Authors: Z Rezaieyazdi; M Sahebari; M R Hatef; B Abbasi; H Rafatpanah; J Tavakol Afshari; H Esmaily Journal: Lupus Date: 2011-10-12 Impact factor: 2.911
Authors: Grace L Rose; Morgan J Farley; Nicole B Flemming; Tina L Skinner; Mia A Schaumberg Journal: Front Physiol Date: 2022-08-22 Impact factor: 4.755